EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effect of oral zonisamide treatment on serum phenobarbital concentrations in epileptic dogs

Elizabeth Mahon, Oliver Marsh, Ane Uriarte, Fabio Stabile

Frontiers in Veterinary Science · 29.05.2024 · 11

DOI: 10.3389/fvets.2024.1389615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Veterinary Science, online erschienen am 29.05.2024. Verfasst von Elizabeth Mahon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Southfields Veterinary Specialists, Part of Linnaeus Ltd, Essex, United Kingdom. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zonisamide is used in dogs for the treatment of epileptic seizures. It is predominantly metabolised by CYP450 hepatic enzymes. When used concurrently with phenobarbital (PB), zonisamide clearance is increased and its elimination half-life decreases. However, the effect that zonisamide may have on serum PB concentrations in dogs has not been previously described. Eight dogs diagnosed with idiopathic epilepsy and two dogs with structural epilepsy commenced zonisamide at 8.0 mg/kg/12 h [7.4–10 mg/kg/12 h] following an increase in the frequency of epileptic seizures. Nine dogs were receiving PB every 12 h (4.2 mg/kg/12 h [3.8–6 mg/kg/12 h]), and one dog was receiving PB every 8 h (6 mg/kg/8 h). Following the addition of zonisamide and despite no increase in PB dosage, an increase in phenobarbital serum PB concentration was observed in 9 out of 10 dogs in subsequent measurements. In five dogs, phenobarbital serum concentrations were raised to concentrations higher than the reported hepatotoxic concentrations (trough>35 mg/L). This required a reduction in daily doses of PB. This case series suggests that zonisamide affects the metabolism of PB and causes an increase in PB serum concentrations over time.

Schlagwörter

Stichwörter der Autor:innen

dogsepilepsyidiopathic epilepsyphenobarbitalstructural epilepsyzonisamide

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery, Southfields Veterinary Specialists, Part of Linnaeus Ltd, Essex, United Kingdom.
  • Department of Neurology and Neurosurgery, Dick White Referrals, Part of Linnaeus Ltd, Newmarket, United Kingdom.
  • Department of Neurology and Neurosurgery, Wear Referrals, Part of Linnaeus Ltd, Bradbury, United Kingdom.

Zitieren

APA

Mahon, E., Marsh, O., Uriarte, A., & Stabile, F. (2024). The effect of oral zonisamide treatment on serum phenobarbital concentrations in epileptic dogs. Frontiers in Veterinary Science, 11. https://doi.org/10.3389/fvets.2024.1389615

Vancouver

Mahon E, Marsh O, Uriarte A, Stabile F. The effect of oral zonisamide treatment on serum phenobarbital concentrations in epileptic dogs. Frontiers in Veterinary Science. 2024;11. doi:10.3389/fvets.2024.1389615

BibTeX
@article{Mahon2024,
  author = {Mahon, Elizabeth and Marsh, Oliver and Uriarte, Ane and Stabile, Fabio},
  title = {The effect of oral zonisamide treatment on serum phenobarbital concentrations in epileptic dogs},
  journal = {Frontiers in Veterinary Science},
  year = {2024},
  volume = {11},
  doi = {10.3389/fvets.2024.1389615}
}
Kostenlos starten →